Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,843,878
-
Share change
-
-3,728,850
-
Total reported value
-
$287,405,299
-
Put/Call ratio
-
170%
-
Price per share
-
$18.14
-
Number of holders
-
96
-
Value change
-
-$65,042,116
-
Number of buys
-
61
-
Number of sells
-
41
Institutional Holders of AKCEA THERAPEUTICS INC - COM (AKCA) as of Q3 2020
As of 30 Sep 2020,
AKCEA THERAPEUTICS INC - COM (AKCA) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,843,878 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, GABELLI FUNDS LLC, WELLS FARGO & COMPANY/MN, CREDIT SUISSE AG/, Bellevue Group AG, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.